Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,801 stories, page 219 of 631

Advanced search

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07776275: Physical Profile of Cervicogenic Headache: Comparison With Neck Pain and Healthy Controls

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07727512: PCOS and Brain Health

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07677358: A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07553065: RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07545590: A Study of Eltrekibart (LY3041658) in Healthy Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07530965: Omega-3-Fatty Acids in Children With Sickle Cell Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07271355: Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07227597: A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07225855: Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07222332: A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07216560: First-in-human Study of 7MW4911 in GI Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07198074: Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07061574: A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT07059845: A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06925737: A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06890884: A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06887036: Methylene Blue Treatment of Chronic Hepatitis B Virus Infection

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06745921: Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06744283: Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06738654: Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06645015: The AIDPRO-CRC Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06576713: Combined Genome and RNA Sequencing for Genetic Diagnosis of Parkinsonism

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06570798: A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06507488: Daphnetin Capsule In the Treatment of VaScular COgnitive Impairment Without Dementia

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06462469: Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT06441890: BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT05893940: Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT05189262: Cardiopulmonary Bypass Induced Red Blood Cell Lysis

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT05065216: Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT04849741: A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT04696315: Early Diagnosis of SCD Based on Radiogenomics

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT03992404: Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT03118492: Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT02716246: Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 21Researchclinicaltrials.govTier 1 · Trial registry

NCT00068003: Harvesting Cells for Experimental Cancer Treatments

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Healthcare Stocks Slipped As Biotech Led Thursday’s Selloff

FinimizeOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

SEC Won't Lift Trading Suspension On Chinese Biotech Firm

Law360Original source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Evaxion Biotech: Strong R&D progress and financial discipline support a cash runway into H2 2027

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Guizhou Bailing Group Pharmaceutical Co., Ltd. Class A – SZSE:002424

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Moderna's mRNA Cancer Vaccine Succeeds in Phase 3 — Korean Biotech Delivery Systems and Combination Strategies Back in Spotlight

finance.biggo.comOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Moderna’s phase 3 mRNA cancer win boosts Korea’s Alteogen, ST Pharm - CHOSUNBIZ

ChosunbizOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Nascent Biotech Inc. – OTC:NBIO

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

When a failed trial isn't a failed drug

Drug Discovery NewsOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Producers keep close eye on pharmaceutical shortages

The Western ProducerOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Personalized mRNA Cancer Vaccine Delays Melanoma Recurrence

조선일보Original source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?

The Motley FoolOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Phase 3 trial of Ebola vaccine begins in the DRC

Chemical & Engineering NewsOriginal source

🌍Aug 21Researchamref.orgTier 2 · Direct publisher

TENDER NO. AMIU/21/08/2026/002 REQUEST FOR PROPOSALS FOR PROVISION OF MANNED SECURITY SERVICES

Amref Health AfricaOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Gains Momentum On An Undervalued Narrative

Yahoo FinanceOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Central Carolina CC Opens New Biotech Facility

GovTechOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

FDA issues highest-risk warning for recalled frozen berries sold at Publix due to E.coli

Local 3 NewsOriginal source

🇿🇦Aug 21Regulatorysahpra.org.zaTier 1 · Regulatory source

SAHPRA Reaffirms the Safety of Routine Childhood Vaccination

SAHPRA South AfricaOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Edesa Biotech Enters Underwriting Deal With Guggenheim for $23.1M Equity Offering

TradingViewOriginal source

🌍Aug 21Industryexozymes.comTier 1 · Company source

eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET today

eXoZymesOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Sterling Biotech

The Pharma LetterOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for Cannabis Use Disorder

Psychiatric TimesOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Solid Phase Extraction: Biotech Fluidics’ SPEedy Device Eliminates Vacuum Manifold Hassles

Lab ManagerOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Why investors should be paying attention to biotech

Yahoo FinanceOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

FDA Approves Pasatru | PharmExec

Pharmaceutical ExecutiveOriginal source